Making Sense of Weight-Loss Drugs’ Cost and Coverage

The discussion dives into the complexities of GLP-1 weight-loss drugs, like Ozempic and Wegovy, highlighting their high out-of-pocket costs, often exceeding $1,000 monthly. It unpacks the disparities in pricing and accessibility, revealing why some consumers face steeper prices than others. The conversation also examines current employer coverage rates, with only 36% providing support, and speculates on the future of drug pricing amid potential Medicare changes and the introduction of generics.